From the Department of Nephrology and Hypertension (J.B.S., U.R., R.E.S., K.-U.E., M.P.S.), Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Division of Nephrology, Department of Medicine, University of Würzburg, Germany (S.T., C.W.).
Hypertension. 2018 Oct;72(4):929-936. doi: 10.1161/HYPERTENSIONAHA.118.11608.
In patients with chronic kidney disease, data on blood pressure (BP) pattern and its association with target organ damage, which indicates elevated cardiovascular risk, are sparse. In 305 treated hypertensive chronic kidney disease patients, we assessed BP pattern, left ventricular mass (magnetic resonance imaging), intima-media thickness (ultrasound), 24-hour-pulse wave velocity and 24-hour-central augmentation index (Mobil-O-Graph). Controlled hypertension (normal office and ambulatory BP) was found in 41% and sustained uncontrolled hypertension (elevated office and ambulatory BP) in 30% of patients. Misclassification of BP status occurred in 29%: white coat uncontrolled hypertension (elevated office but normal ambulatory BP) was detected in 11% and masked uncontrolled hypertension (normal office but elevated ambulatory BP) in 18% of patients. Left ventricular mass was increased in white coat uncontrolled hypertension (+11.2 g), masked uncontrolled hypertension (+9.4 g), and sustained uncontrolled hypertension (+16.6 g) compared with controlled hypertension. Intima-media thickness was similar across all 4 BP groups. Twenty-four hour-pulse wave velocity and 24-hour-central augmentation index were increased in masked uncontrolled hypertension (+0.5 m/sec and +2.5%) and sustained uncontrolled hypertension (+0.5 m/sec and +2.9%) compared with controlled hypertension. In conclusion, based on office BP measurements, misclassification of true BP status occurred in almost one-third of chronic kidney disease patients. Both types of misclassification (white coat uncontrolled hypertension and masked uncontrolled hypertension) were associated with parameters of target organ damage. Ambulatory BP monitoring should be used routinely to identify chronic kidney disease patients at high cardiovascular risk.
在慢性肾脏病患者中,有关血压(BP)模式及其与靶器官损害的关系的数据(提示心血管风险升高)较为缺乏。我们在 305 例接受治疗的高血压慢性肾脏病患者中评估了 BP 模式、左心室质量(磁共振成像)、内膜中层厚度(超声)、24 小时脉搏波速度和 24 小时中心动脉增强指数(Mobil-O-Graph)。41%的患者血压得到了有效控制(诊室和动态血压正常),30%的患者持续性血压未得到有效控制(诊室和动态血压升高)。血压状态的错误分类发生在 29%的患者中:11%的患者为白大衣未控制的高血压(诊室血压升高但动态血压正常),18%的患者为隐匿性未控制的高血压(诊室血压正常但动态血压升高)。与血压控制良好的患者相比,白大衣未控制的高血压(+11.2g)、隐匿性未控制的高血压(+9.4g)和持续性未控制的高血压(+16.6g)患者的左心室质量增加。所有 4 组 BP 患者的内膜中层厚度相似。与血压控制良好的患者相比,隐匿性未控制的高血压(+0.5m/sec 和+2.5%)和持续性未控制的高血压(+0.5m/sec 和+2.9%)患者的 24 小时脉搏波速度和 24 小时中心动脉增强指数增加。总之,根据诊室 BP 测量结果,近三分之一的慢性肾脏病患者存在真正的 BP 状态错误分类。这两种类型的错误分类(白大衣未控制的高血压和隐匿性未控制的高血压)均与靶器官损害的参数相关。应常规使用动态血压监测来识别心血管风险较高的慢性肾脏病患者。